Industry Verticals »

All Categories

Insights »

About TMR »

Chemiluminescence Immunoassay (CLIA) Analyzers Market

Chemiluminescence Immunoassay (CLIA) Analyzers Market (Product - Analyzers (Automated and Semi-automated), Reagents (Enzymatic Markers and Luminophore Markers), Consumables; Application - Endocrine Disorders, Oncology, Infectious Diseases, Hepatitis & Retrovirus, Cardiovascular Disorders, Allergy, Autoimmunity, and Drug Discovery & Development; End User - Hospitals, Clinical Laboratories, and Pharmaceutical & Biotechnology Industries) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

  • According to Transparency Market Research’s latest report on the global chemiluminescence immunoassay (CLIA) analyzers market for the historical period 2017 - 2018 and forecast period 2019-2027, high incidence & prevalence of chronic diseases to escalate the growth of global chemiluminescence immunoassay (CLIA) analyzers market. Moreover, increase in demand for laboratory automation is boost the growth of market
  • According to the report, the global chemiluminescence immunoassay (CLIA) analyzers market was valued at US$ 5.04 Bn in 2018 and is anticipated to expand at a CAGR of 6.3% from 2019 to 2027

Growing Demand for International Accreditations and Result Comparability Using High Throughput Automated Immunoassays and Increase in Prevalence of Chronic Diseases : Key Drivers of Global Chemiluminescence Immunoassay (CLIA) Analyzers Market

  • Sedentary lifestyle and unhealthy diet is leading to surge in prevalence & incidence of chronic diseases. For instance, according to World Health Organization (WHO), in 2018 cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths globally.  
  • Chronic disease prevalence has increased over time due to an aging population. Moreover, smoking, and body mass index, which are widely known risk factors for chronic diseases such as cancer, cardiovascular disease, etc. thus rise in prevalence of various chronic diseases propel the growth of market
  • Moreover, major focus of physicians and pathologists operating in in-patient or out-patient settings of the chemiluminescence immunoassay (CLIA) analyzers market is to improve the rate of standardization of the assays. The main objective behind calibration of the assays is to compare the results of the test to the well-established standards while handing out the test results to patients.
  • The CLIA instruments are closed system multiplexed automated analyzers along with high throughput. These systems are relatively easy to calibrate. The CLIA analyzers are manufactured as per guidelines set by regulatory authorities. The CLIA test manufacturers also offer internal reference standard material to make their results more comparable when compared with other manual assay systems.
  • Thus, growing demand for international accreditations and result comparability using high throughput automated immunoassays is likely to drive the global chemiluminescence immunoassay (CLIA) analyzers market
  • To address these demands, the industry players are investing in the research and development activities to develop and introduce new products thereby boosting the global chemiluminescence immunoassay (CLIA) analyzers market

Technological Advancements Propel Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Growth

  • A major technological trend observed in the global chemiluminescence immunoassay analyzers market is the introduction of next-generation integrated immunoassays. For instance, in October 31, 2017, Abbott announced the FDA 510(k) clearance for Alinity ci-series, instruments for clinical chemistry and immunoassay diagnostics. This innovation in multiplexed assays is likely to drive the global CLIA analyzers market during the forecast period
  • Moreover, major manufacturers operating in the global CLIA analyzers market are involved in the expansion of their test portfolio through continuous research and development activities. For instance, in December 26, 2017, Danaher (Beckman Coulter, Inc.) received FDA clearance for its Access AMH immunoassay, the first immunoassay that uses recombinant human antigens for determination of anti-Müllerian hormone (AMH) levels. The increasing preference for continuous research with an objective of expansion of test portfolio by major as well as emerging players is likely to result in growth of the global CLIA analyzers market during the forecast period

Fragmented Consumables Market Affecting Profit Margin to Hamper Global Chemiluminescence Immunoassay (CLIA) Analyzers Market

  • Continuous expansion of test offering portfolio has resulted in increasing number of emerging market players offering test kits for specific test application at affordable prices
  • Product offering at relatively lower average selling price has resulted in increasing market penetration of local players having wide distribution network in certain geographies
  • This is imposing pricing pressure on major manufacturers, thereby intensifying competition. Additionally, there are other technology alternatives that are available in the market at relatively lower cost per procedure, which is also affecting the geographic expansion of major players.

Global Chemiluminescence Immunoassay (CLIA) Analyzers Market: Competitive Landscape

  • This report profiles major players in the global chemiluminescence immunoassay (CLIA) analyzers market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global chemiluminescence immunoassay (CLIA) analyzers market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global chemiluminescence immunoassay (CLIA) analyzers market are -
    • Abbott
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthineers (Siemens AG)
    • Danaher (Beckman Coulter, Inc.)
    • DiaSorin S.p.A
    • Ortho Clinical Diagnostics (Part of Carlyle Group)
    • Shenzhen New Industries Biomedical Engineering Co., Ltd.
    • Sysmex Corporation
    • Randox Laboratories Ltd.
    • Tosoh Corporation

Global Chemiluminescence Immunoassay (CLIA) Analyzers Market: Key Developments

Key players in the global chemiluminescence immunoassay (CLIA) analyzers market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global chemiluminescence immunoassay (CLIA) analyzers market. A few expansion strategies adopted by players operating in the global chemiluminescence immunoassay (CLIA) analyzers market are:

  • In June 2020, Abbott announced that it has begun supply of its laboratory-based serology blood test for the detection of the antibody, IgG for identification if COVID-19. This is enabled to contribute to ICMR’s COVID-19 antibody testing strategy to use IgG CLIA antibody tests
  • In January 2018, DiaSorin S.p.A. partnered with QIAGEN N.V. to add the latter’s QuantiFERON-TB diagnostic test to the former’s LIAISON family of fully automated analyzers.
  • In October, 2017, Abbott announced the acquisition of Alere Inc., a provider of diagnostic devices and services

The report on the global chemiluminescence immunoassay (CLIA) analyzers market discussed individual strategies, followed by company profiles of manufacturers of chemiluminescence immunoassay (CLIA) analyzers. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global chemiluminescence immunoassay (CLIA) analyzers market.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Chemiluminescence Immunoassay (CLIA) Analyzers Market 

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Chemiluminescence Immunoassay (CLIA) Analyzers Market  Analysis and Forecasts, 2017–2027

5. Key Insights

    5.1. Disease Prevalence & Incidence Rate globally with key countries

    5.2. Technological Advancements

    5.3. Top 3 players operating in the market space

    5.4. Healthcare Industry Overview

6. Global Chemiluminescence Immunoassay (CLIA) Analyzers Market  Analysis and Forecasts, By Product

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Value  Forecast By Product, 2017–2027

        6.3.1. Analyzers

            6.3.1.1. Fully automated

            6.3.1.2. Semi-automated

        6.3.2. Reagents

            6.3.2.1. Luminophore Markers

            6.3.2.2. Enzymatic Markers

        6.3.3. Consumables

    6.4. Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness By Product

7. Global Chemiluminescence Immunoassay (CLIA) Analyzers Market  Analysis and Forecasts, By Application

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Value  Forecast By Application, 2017–2027

        7.3.1. Endocrine Disorders

        7.3.2. Oncology

        7.3.3. Infectious Diseases

        7.3.4. Hepatitis and Retrovirus

        7.3.5. Cardiovascular Disorders

        7.3.6. Allergy

        7.3.7. Autoimmunity

        7.3.8. Drug Discovery & Development

        7.3.9. Others

    7.4. Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness By Application

8. Global Chemiluminescence Immunoassay (CLIA) Analyzers Market  Analysis and Forecasts, By End-user

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Value  Forecast By End-user, 2017–2027

        8.3.1. Hospitals

        8.3.2. Clinical Laboratories

        8.3.3. Pharmaceutical & Biotechnology Industries

        8.3.4. Others

    8.4. Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness By End-user

9. Global Chemiluminescence Immunoassay (CLIA) Analyzers Market  Analysis and Forecasts, By Region

    9.1. Key Findings

    9.2. Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Value  Forecast By Region

        9.2.1. North America 

        9.2.2. Europe 

        9.2.3. Asia Pacific 

        9.2.4. Latin America 

        9.2.5. Middle East & Africa 

    9.3. Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness By Country/Region

10. North America Chemiluminescence Immunoassay (CLIA) Analyzers Market  Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. North America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value  Forecast By Product, 2017–2027

        10.2.1. Analyzers

            10.2.1.1. Fully automated

            10.2.1.2. Semi-automated

        10.2.2. Reagents

            10.2.2.1. Luminophore Markers

            10.2.2.2. Enzymatic Markers

        10.2.3. Consumables

    10.3. North America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value  Forecast By Application, 2017–2027

        10.3.1. Endocrine Disorders

        10.3.2. Oncology

        10.3.3. Infectious Diseases

        10.3.4. Hepatitis and Retrovirus

        10.3.5. Cardiovascular Disorders

        10.3.6. Allergy

        10.3.7. Autoimmunity

        10.3.8. Drug Discovery & Development

        10.3.9. Others

    10.4. North America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value  Forecast By End-user, 2017–2027

        10.4.1. Hospitals

        10.4.2. Clinical Laboratories

        10.4.3. Pharmaceutical & Biotechnology Industries

        10.4.4. Others

    10.5. North America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value  Forecast By Country, 2017–2027

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness Analysis 

        10.6.1. By Product

        10.6.2. By Application

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Chemiluminescence Immunoassay (CLIA) Analyzers Market  Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Europe Chemiluminescence Immunoassay (CLIA) Analyzers Market Value  Forecast By Product, 2017–2027

        11.2.1. Analyzers

            11.2.1.1. Fully automated

            11.2.1.2. Semi-automated

        11.2.2. Reagents

            11.2.2.1. Luminophore Markers

            11.2.2.2. Enzymatic Markers

        11.2.3. Consumables

    11.3. Europe Chemiluminescence Immunoassay (CLIA) Analyzers Market Value  Forecast By Application, 2017–2027

        11.3.1. Endocrine Disorders

        11.3.2. Oncology

        11.3.3. Infectious Diseases

        11.3.4. Hepatitis and Retrovirus

        11.3.5. Cardiovascular Disorders

        11.3.6. Allergy

        11.3.7. Autoimmunity

        11.3.8. Drug Discovery & Development

        11.3.9. Others

    11.4. Europe Chemiluminescence Immunoassay (CLIA) Analyzers Market Value  Forecast By End-user, 2017–2027

        11.4.1. Hospitals

        11.4.2. Clinical Laboratories

        11.4.3. Pharmaceutical & Biotechnology Industries

        11.4.4. Others

    11.5. Europe Chemiluminescence Immunoassay (CLIA) Analyzers Market Value  Forecast By Country/Sub-region, 2017–2027

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Europe Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness Analysis 

        11.6.1. By Product

        11.6.2. By Application

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market  Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Value  Forecast By Product, 2017–2027

        12.2.1. Analyzers

            12.2.1.1. Fully automated

            12.2.1.2. Semi-automated

        12.2.2. Reagents

            12.2.2.1. Luminophore Markers

            12.2.2.2. Enzymatic Markers

        12.2.3. Consumables

    12.3. Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Value  Forecast By Application, 2017–2027

        12.3.1. Endocrine Disorders

        12.3.2. Oncology

        12.3.3. Infectious Diseases

        12.3.4. Hepatitis and Retrovirus

        12.3.5. Cardiovascular Disorders

        12.3.6. Allergy

        12.3.7. Autoimmunity

        12.3.8. Drug Discovery & Development

        12.3.9. Others

    12.4. Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Value  Forecast By End-user, 2017–2027

        12.4.1. Hospitals

        12.4.2. Clinical Laboratories

        12.4.3. Pharmaceutical & Biotechnology Industries

        12.4.4. Others

    12.5. Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Value  Forecast By Country/Sub-region, 2017–2027

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness Analysis 

        12.6.1. By Product

        12.6.2. By Application

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Latin America Chemiluminescence Immunoassay (CLIA) Analyzers Market  Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Latin America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value  Forecast By Product, 2017–2027

        13.2.1. Analyzers

            13.2.1.1. Fully automated

            13.2.1.2. Semi-automated

        13.2.2. Reagents

            13.2.2.1. Luminophore Markers

            13.2.2.2. Enzymatic Markers

        13.2.3. Consumables

    13.3. Latin America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value  Forecast By Application, 2017–2027

        13.3.1. Endocrine Disorders

        13.3.2. Oncology

        13.3.3. Infectious Diseases

        13.3.4. Hepatitis and Retrovirus

        13.3.5. Cardiovascular Disorders

        13.3.6. Allergy

        13.3.7. Autoimmunity

        13.3.8. Drug Discovery & Development

        13.3.9. Others

    13.4. Latin America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value  Forecast By End-user, 2017–2027

        13.4.1. Hospitals

        13.4.2. Clinical Laboratories

        13.4.3. Pharmaceutical & Biotechnology Industries

        13.4.4. Others

    13.5.  Latin America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value  Forecast By Country/Sub-region, 2017–2027

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness Analysis 

        13.6.1. By Product

        13.6.2. By Application

        13.6.3. By End-user

        13.6.4. By Country/Sub-region 

14. Middle East & Africa Chemiluminescence Immunoassay (CLIA) Analyzers Market  Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Middle East & Africa Chemiluminescence Immunoassay (CLIA) Analyzers Market Value  Forecast By Product, 2017–2027

        14.2.1. Analyzers

            14.2.1.1. Fully automated

            14.2.1.2. Semi-automated

        14.2.2. Reagents

            14.2.2.1. Luminophore Markers

            14.2.2.2. Enzymatic Markers

        14.2.3. Consumables

    14.3. Middle East & Africa Chemiluminescence Immunoassay (CLIA) Analyzers Market Value  Forecast By Application, 2017–2027

        14.3.1. Endocrine Disorders

        14.3.2. Oncology

        14.3.3. Infectious Diseases

        14.3.4. Hepatitis and Retrovirus

        14.3.5. Cardiovascular Disorders

        14.3.6. Allergy

        14.3.7. Autoimmunity

        14.3.8. Drug Discovery & Development

        14.3.9. Others

    14.4. Middle East & Africa Chemiluminescence Immunoassay (CLIA) Analyzers Market Value  Forecast By End-user, 2017–2027

        14.4.1. Hospitals

        14.4.2. Clinical Laboratories

        14.4.3. Pharmaceutical & Biotechnology Industries

        14.4.4. Others

    14.5. Middle East & Africa Chemiluminescence Immunoassay (CLIA) Analyzers Market Value  Forecast By Country/Sub-region, 2017–2027

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Middle East & Africa Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness Analysis 

        14.6.1. By Product

        14.6.2. By Application

        14.6.3. By End-user

        14.6.4. By Country/Sub-region 

15. Competition Landscape

    15.1. Market Player – Competition Matrix (By Tier and Size of companies)

    15.2. Market Share Analysis/Ranking  By Company (2018)

    15.3. Company Profiles

        15.3.1. Abbott

            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.1.2. Growth Strategies

            15.3.1.3. SWOT Analysis. 

        15.3.2. F. Hoffmann-La Roche Ltd 

            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.2.2. Growth Strategies

            15.3.2.3. SWOT Analysis. 

        15.3.3. Siemens Healthineers (Siemens AG)

            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.3.2. Growth Strategies

            15.3.3.3. SWOT Analysis. 

        15.3.4. Danaher (Beckman Coulter, Inc.) 

            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.4.2. Growth Strategies

            15.3.4.3. SWOT Analysis. 

        15.3.5. DiaSorin S.p.A

            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.5.2. Growth Strategies

            15.3.5.3. SWOT Analysis. 

        15.3.6. Ortho Clinical Diagnostics (Part of Carlyle Group) 

            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.6.2. Growth Strategies

            15.3.6.3. SWOT Analysis. 

        15.3.7. Shenzhen New Industries Biomedical Engineering Co., Ltd.

            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.7.2. Growth Strategies

            15.3.7.3. SWOT Analysis. 

        15.3.8. Sysmex Corporation 

            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.8.2. Growth Strategies

            15.3.8.3. SWOT Analysis. 

        15.3.9. Randox Laboratories Ltd. 

            15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.9.2. Growth Strategies

            15.3.9.3. SWOT Analysis. 

        15.3.10. Tosoh Corporation

            15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.10.2. Growth Strategies

            15.3.10.3. SWOT Analysis.

List of Table

Table 01: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 02: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Analyzers, 2017–2027

Table 03: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Reagents, 2017–2027

Table 04: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 05: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 06: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Size (US$ Mn) Forecast, by Region, 2017–2027

Table 07: North America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 08: North America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 09: North America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Analyzers, 2017–2027

Table 10: North America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Reagents, 2017–2027

Table 11: North America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 12: North America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 13: Europe Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 14: Europe Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 15: Europe Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Analyzers, 2017–2027

Table 16: Europe Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Reagents, 2017–2027

Table 17: Europe Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 18: Europe Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 19: Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 20: Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 21: Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Analyzers, 2017–2027

Table 22: Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Reagents, 2017–2027

Table 23: Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 24: Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 25: Latin America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 26: Latin America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 27: Latin America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Analyzers, 2017–2027

Table 28: Latin America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Reagents, 2017–2027

Table 29: Latin America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 30: Latin America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 31: Middle East & Africa Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 32: Middle East & Africa Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 33: Middle East & Africa Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Analyzers, 2017–2027

Table 34: Middle East & Africa Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Reagents, 2017–2027

Table 35: Middle East & Africa Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 36: Middle East & Africa Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, by End-user, 2017–2027

List of Figure

Figure 01: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Size (US$ Mn) and Distribution (%), by Region, 2018 and 2027

Figure 02: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast, 2017–2027

Figure 03: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market  Value Share, by Product (2018)

Figure 04: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market  Value Share, by Application (2018)

Figure 05: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market  Value Share, by End-user (2018)

Figure 06: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market  Value Share, by Region (2018)

Figure 07: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Value Share, by Product, 2018 and 2027

Figure 08: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Analyzers, 2017–2027

Figure 09: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Reagents, 2017–2027

Figure 10: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Consumables, 2017–2027

Figure 11: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness, by Product, 2019–2027

Figure 12: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Value Share, by Application, 2018 and 2027

Figure 13: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Endocrine Disorders, 2017–2027

Figure 14: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Oncology, 2017–2027

Figure 15: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Infectious Diseases, 2017–2027

Figure 16: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hepatitis & Retrovirus, 2017–2027

Figure 17: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Cardiovascular Disorders, 2017–2027

Figure 18: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Allergy, 2017–2027

Figure 19: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Autoimmunity, 2017–2027

Figure 20: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Drug Discovery & Development, 2017–2027

Figure 21: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017–2027

Figure 22: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness, by Application, 2019–2027

Figure 23: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Value Share, by End-user, 2018 and 2027

Figure 24: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospitals, 2017–2027

Figure 25: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Clinical Laboratories, 2017–2027

Figure 26: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Pharmaceutical & Biotechnology Industries, 2017–2027

Figure 27: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017–2027

Figure 28: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness, by End-user, 2019–2027

Figure 29: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Value Share, by Region, 2018 and 2027

Figure 30: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness, by Region, 2019–2027

Figure 31: North America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

Figure 32: North America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value Share, by Country, 2018 and 2027

Figure 33: North America Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness, by Country, 2019–2027

Figure 34: North America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value Share, by Product, 2018 and 2027

Figure 35: North America Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness, by Product, 2019–2027

Figure 36: North America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value Share, by Application, 2018 and 2027

Figure 37: North America Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness, by Application, 2019–2027

Figure 38: North America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value Share, by End-user, 2018 and 2027

Figure 39: North America Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness, by End-user, 2019–2027

Figure 40: Europe Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 41: Europe Chemiluminescence Immunoassay (CLIA) Analyzers Market Value Share, by Country/Sub-region, 2018 and 2027 

Figure 42: Europe Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 43: Europe Chemiluminescence Immunoassay (CLIA) Analyzers Market Value Share, by Product, 2018 and 2027

Figure 44: Europe Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness, by Product, 2019–2027

Figure 45: Europe Chemiluminescence Immunoassay (CLIA) Analyzers Market Value Share, by Application, 2018 and 2027

Figure 46: Europe Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness, by Application, 2019–2027

Figure 47: Europe Chemiluminescence Immunoassay (CLIA) Analyzers Market Value Share, by End-user, 2018 and 2027

Figure 48: Europe Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness, by End-user, 2019–2027

Figure 49: Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 50: Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Value Share, by Country/Sub-region, 2018 and 2027 

Figure 51: Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 52: Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Value Share, by Product, 2018 and 2027

Figure 53: Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness, by Product, 2019–2027

Figure 54: Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Value Share, by Application, 2018 and 2027

Figure 55: Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness, by Application, 2019–2027

Figure 56: Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Value Share, by End-user, 2018 and 2027

Figure 57: Asia Pacific Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness, by End-user, 2019–2027

Figure 58: Latin America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 59: Latin America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value Share, by Country/Sub-region, 2018 and 2027 

Figure 60: Latin America Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 61: Latin America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value Share, by Product, 2018 and 2027

Figure 62: Latin America Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness, by Product, 2019–2027

Figure 63: Latin America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value Share, by Application, 2018 and 2027

Figure 64: Latin America Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness, by Application, 2019–2027

Figure 65: Latin America Chemiluminescence Immunoassay (CLIA) Analyzers Market Value Share, by End-user, 2018 and 2027

Figure 66: Latin America Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness, by End-user, 2019–2027

Figure 67: Middle East & Africa Chemiluminescence Immunoassay (CLIA) Analyzers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 68: Middle East & Africa Chemiluminescence Immunoassay (CLIA) Analyzers Market Value Share, by Country/Sub-region, 2018 and 2027 

Figure 69: Middle East & Africa Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 70: Middle East & Africa Chemiluminescence Immunoassay (CLIA) Analyzers Market Value Share, by Product, 2018 and 2027

Figure 71: Middle East & Africa Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness, by Product, 2019–2027

Figure 72: Middle East & Africa Chemiluminescence Immunoassay (CLIA) Analyzers Market Value Share, by Application, 2018 and 2027

Figure 73: Middle East & Africa Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness, by Application, 2019–2027

Figure 74: Middle East & Africa Chemiluminescence Immunoassay (CLIA) Analyzers Market Value Share, by End-user, 2018 and 2027

Figure 75: Middle East & Africa Chemiluminescence Immunoassay (CLIA) Analyzers Market Attractiveness, by End-user, 2019–2027

Figure 76: Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Share, by Company, 2018

Copyright © Transparency Market Research, Inc. All Rights reserved

Chemiluminescence Immunoassay (CLIA) Analyzers Market

Schedule a Call